HCPCS Code “q5134” To NDC Mapping Options

“q5134” To NDC Crosswalk(s)

Source HCPCS Code

Target NDC Code

Q5134
Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg

61314-0543-94
TYRUKO 300 MG/15 ML VIAL

Detail Information

Relationship Start Date	04/01/2026
Relationship End Date	12/31/3999
Number Of Items In Ndc Package	15
Ndc Package Measure	ML
Ndc Package Type	VIAL
Route Of Administration	IV
Billing Units	ML

Q5134
Inj, tyruko, 1 mg

61314-0543-94
Tyruko

Detail Information

Relationship Start Date
Relationship End Date
Number Of Items In Ndc Package
Ndc Package Measure
Ndc Package Type
Route Of Administration
Billing Units